Rong-Zhen Li
Overview
Explore the profile of Rong-Zhen Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su L, Zhang L, Yuan T, Ji L, Liu M, Li R, et al.
Skin Res Technol
. 2024 Apr;
30(4):e13652.
PMID: 38572582
Objective: To investigate whether compression therapy after thermal ablation of varicose veins can improve the prognosis of patients. Methods: Systematic research were applied for Chinese and English electronic databases(PubMed, Web...
2.
Yuan Y, Xie W, Li R, Chang H, Zeng Z, Gao Y, et al.
Cancer Med
. 2021 Nov;
11(1):117-127.
PMID: 34816622
Background: Anal squamous cell carcinoma (ASCC) is a rare malignant tumor with increasing incidence. The goal of our study was to analyze the treatment outcome and prognostic factors of ASCC...
3.
Tan H, Guan X, Hu M, Wu J, Li R, Wang L, et al.
Stem Cell Res Ther
. 2021 Jun;
12(1):364.
PMID: 34174964
Background: Obesity is a metabolic disorder syndrome characterized by excessive fat accumulation that is related to many diseases. Human amniotic mesenchymal stem cells (hAMSCs) have a great potential for cell-based...
4.
Zhang S, Zhang R, Li R, Wang Q, Chang H, Ding P, et al.
Cancer Sci
. 2021 Jun;
112(9):3607-3615.
PMID: 34146368
This study aimed to identify patients who benefit from radical surgery among those with rectal cancer who achieved clinical complete response (cCR). Patients with locally advanced rectal cancer (LARC; stage...
5.
Niu S, Li R, Yuan Y, Xie W, Wang Q, Chang H, et al.
Radiat Oncol
. 2021 May;
16(1):93.
PMID: 34030722
Background: Patients with locally advanced sigmoid colon cancer (LASCC) have limited treatment options and a dismal prognosis with poor quality of life. This retrospective study aimed to further evaluate the...
6.
Yuan Y, Xiao W, Xie W, Li R, Gao Y
BMC Cancer
. 2021 May;
21(1):479.
PMID: 33931024
Background: Ubiquitin-conjugating enzyme E2W (UBE2W) is a protein-coding gene that has an important role in ubiquitination and may be vital in the repair of DNA damage. However, studies on the...
7.
Lin X, Li S, Zhou C, Li R, Wang H, Luo W, et al.
Int J Biochem Cell Biol
. 2019 Sep;
116:105610.
PMID: 31518663
It has been proposed that the aberrant expressions of the classical apoptosis-related genes and the subsequent decrease of apoptosis contribute to the development of cisplatin resistance in gastric cancer. However,...
8.
Huang Y, Wang T, Lin X, Wang H, Li R, Zeng X, et al.
Anticancer Drugs
. 2019 Sep;
30(10):973-982.
PMID: 31503014
Fibroblast growth factor-2 (FGF2) is a protein ligand, which exerts essential roles in development, angiogenesis, and tumor progression via activation of the downstream signaling cascades. Accumulating evidence has demonstrated that...
9.
Lin X, Luo W, Wang H, Li R, Huang Y, Chen L, et al.
Front Pharmacol
. 2019 Aug;
10:836.
PMID: 31440159
The prostaglandin-endoperoxide synthase-2 (PTGS2) plays essential roles in diverse pathological process. Although recent studies implied that PTGS2 was closely related with chemoresistance, the precise roles and the underlying mechanisms of...
10.
Luo W, Lin X, Wang T, Cai J, Zeng X, Zhu C, et al.
J Cell Physiol
. 2018 Oct;
234(3):2500-2510.
PMID: 30317562
Previous studies suggest that specific binding to the complex consisting of fibroblast growth factor receptor-1 (FGFR1) and the coreceptor beta-Klotho (KLB) is the premise for human FGF19 and FGF21 activating...